Feixia Wang
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
- Epidemiology 27
- Liver Disease Diagnosis and Treatment 22
- Hepatitis B Virus Studies 4
- Autophagy in Disease and Therapy 4
- Hepatology 20
- Liver physiology and pathology 12
- Liver Disease and Transplantation 5
- Co-authors
- Shizhong Zheng (34 shared papers)Jiangjuan Shao (31 shared papers)Zili Zhang (24 shared papers)Feng Zhang (15 shared papers)Yan Jia (7 shared papers)Shanzhong Tan (14 shared papers)Mengmeng Li (5 shared papers)Anping Chen (5 shared papers)
- Journals
- BioFactors (2 papers)Journal of Ethnopharmacology (2 papers)IUBMB Life (2 papers)British Journal of Pharmacology (2 papers)Pharmacological Research (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Feixia Wang
40 papers receiving 1.2k citations
Feixia Wang's Hit Papers
Peers
Comparison fields: 5 of 92
- Hepatology 278
- Cancer Research 269
- Pharmacology 106
- Epidemiology 397
- Molecular Biology 554
Countries citing papers authored by Feixia Wang
This map shows the geographic impact of Feixia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feixia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feixia Wang more than expected).
Fields of papers citing papers by Feixia Wang
This network shows the impact of papers produced by Feixia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feixia Wang. The network helps show where Feixia Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feixia Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 135 | |
| 2 | 2018 | 124 | |
| 3 | 2020 | 84 | |
| 4 | Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A/HIF-1α transcriptional complex Hit paper breakdown → | 2023 | 75 |
| 5 | 2020 | 72 | |
| 6 | 2017 | 60 | |
| 7 | 2019 | 44 | |
| 8 | 2019 | 44 | |
| 9 | 2022 | 43 | |
| 10 | 2020 | 41 | |
| 11 | 2023 | 40 | |
| 12 | 2020 | 39 | |
| 13 | 2021 | 36 | |
| 14 | 2022 | 31 | |
| 15 | 2017 | 31 | |
| 16 | 2020 | 24 | |
| 17 | 2019 | 24 | |
| 18 | 2020 | 21 | |
| 19 | 2023 | 20 | |
| 20 | 2022 | 19 |
About Feixia Wang
Feixia Wang is a scholar working on Epidemiology, Hepatology, Molecular Biology, Cancer Research and Immunology, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Liver physiology and pathology (12 papers), Liver Disease and Transplantation (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (5 papers), Hepatitis B Virus Studies (4 papers), interferon and immune responses (4 papers) and Autophagy in Disease and Therapy (4 papers). The work is most often cited by research in Hepatology (278 citations), Cancer Research (269 citations), Pharmacology (106 citations), Epidemiology (397 citations) and Molecular Biology (554 citations). Feixia Wang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Shizhong Zheng, Jiangjuan Shao, Zili Zhang, Feng Zhang, Yan Jia, Shanzhong Tan, Mengmeng Li, Anping Chen, Anping Chen and Siwei Xia. Their work appears in journals such as BioFactors, Journal of Ethnopharmacology, IUBMB Life, British Journal of Pharmacology and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.